Neuro-Oncology Reviews
Volume
28 Number 16
10 June 2026
Home > Publications > Neuro-Oncology Reviews > Volume 28, Year 2026 > Number 16, 10 June
Salam SA, Tanoy NM, Sabuj MSS, Rahman MJ, Sadekuzzaman M,
Chowdhury S, Jahan E, Siddiqui MSI, Park BY, Akanda MR.
MGMT
promoter methylation in glioblastoma: Molecular mechanisms, tumor
microenvironment interactions, and therapeutic implications.
Pathol
Res Pract. 2026 Jun 8;286:156585. doi:
10.1016/j.prp.2026.156585. PMID:
42263464˰ ˍ
Schreck KC, de la Fuente MI, Fat MJL, Maas SLN, Mulcahy Levy JM,
Lombardi G, Perrault S, Petritsch CK, Aldape K, Chang SM, Duerinck
J, Holdhoff M, Kazda T, Rhun EL, Minniti G, Mishra MV, Mueller S,
Padovan M, Preusser M, Smits M, Weller M, Wen PY, van den Bent M,
Geurts M.
BRAF-altered glioma in
adults and children: A Society for Neuro-Oncology (SNO) and
European Society for Neuro-Oncology (EANO) consensus review on
clinical management and future directions.
Neuro
Oncol. 2026 Jun 8:noag135. doi:
10.1093/neuonc/noag135. PMID:
42261252˰ ˍ
Wang W, Shen X, Tan X, Wang Y, Li D, Chen Y, Wu S.
Mapping
the landscape and evolution of drug delivery for glioma: a
bibliometric and visual analysis.
Discov
Oncol. 2026 Jun 8. doi:
10.1007/s12672-026-05406-1. PMID:
42257777. ˍ
Yamamoto K, Iwase A, Maeda H.
Tumor-Specific
Success Probabilities and Factors Associated With Phase III Trials
in Oncology Drug Development.
Clin
Transl Sci. 2026 Jun 8;19(6):e70635. doi:
10.1111/cts.70635. PMID:
42257532. ˍ
Molinari NC, Lusi V, Bianconi A, De Pasquale D, Giunti D, Fiaschi
P, Cerutti E.
Molecular insights into
DNA damage response plasticity in glioma stem cells.
Commun
Biol. 2026 Jun 9;9(1):777. doi:
10.1038/s42003-026-10467-7. PMID:
42260303. ˍ
Ward M, Brown EDL, Maity A, Larry Lo SF, Sciubba DM.
Intramedullary Spinal Cord Tumors in
the Elderly Patient.
Neurosurg
Clin N Am. 2026 Apr 1;37(3):363-376. doi:
10.1016/j.nec.2026.02.005. PMID:
42264665˰ ˍ
Patel T, Yousuf Ibrahim H, Khan T, Tabrez T, Hussain S, Fatima A,
Junaid Siddiqui A, Anand N.
From
competition to complementarity: narrative review of laser
interstitial thermal therapy, focused ultrasound, and
radiofrequency ablation in minimally invasive neurosurgery.
Ann
Med Surg (Lond). 2026 Apr 7;88(6):3265-3275. doi:
10.1097/MS9.0000000000004916. PMID:
42254235. ˍ
Wang AC, Ho WS, Baird LC.
The
molecular profile of gliomas in adolescents and young adults.
Neurooncol
Adv. 2026 Apr 10;8(Suppl 3):iii72-iii78. doi:
10.1093/noajnl/vdag079. PMID:
42221979. ˍ
Cruz Flores VA, Nieves Rivera CE, Stapleton S.
Treatment
Strategies of Intramedullary Spinal Cord Tumors.
Neurosurg
Clin N Am. 2026 Apr 22;37(3):419-426. doi:
10.1016/j.nec.2026.03.004. PMID:
42264670˰ ˍ
Arif A, Merchant TE.
Radiation Therapy
for Spinal Cord Tumors.
Neurosurg
Clin N Am. 2026 Apr 27;37(3):427-437. doi:
10.1016/j.nec.2026.03.005. PMID:
42264671˰ ˍ
Lehner KR, Xia Y, Groves ML.
Intramedullary
Spinal Cord Tumors in Pediatric Patients.
Neurosurg
Clin N Am. 2026 Apr 29;37(3):317-329. doi:
10.1016/j.nec.2026.03.009. PMID:
42264662˰ ˍ
Halac E, Begagic E, Pojskic M, Arnautovic K.
Treatment
Strategies and Outcomes for Spinal Low-grade Gliomas: A Systematic
Review of the Past Quarter Century.
Neurosurg
Clin N Am. 2026 May 6;37(3):331-351. doi:
10.1016/j.nec.2026.03.008. PMID:
42264663˰ ˍ
Ciafarone A, Palumbo P.
The evolution
of chemotherapy in brain tumors: from historical milestones to
precision medicine in glioblastoma.
Explor
Target Antitumor Ther. 2026 May 21;7:1002374. doi:
10.37349/etat.2026.1002374. PMID:
42222273. ˍ
Wang J, Peng B, Li T, Wang T.
Glioma-derived
extracellular vesicles as drivers of immunotherapeutic resistance:
mechanisms of immune reprogramming and metabolic intervention.
Front
Immunol. 2026 May 22;17:1859282. doi:
10.3389/fimmu.2026.1859282. PMID:
42253953. ˍ